Analysts expect Phathom Pharmaceuticals, Inc. to report revenue of 102.69 M for Q4 26, against a range of 98.76 M to 106.62 M. The most recent reported quarter, Q3 26, came in at 84.72 M, a 3.7% beat against the 81.71 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 29.66 M | 28.52 M | 39.50 M | 49.50 M | 57.58 M | 58.30 M | 74.27 M | 84.72 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 24.13 M | 28.67 M | 36.90 M | 53.57 M | 55.33 M | 58.66 M | 81.31 M | 89.40 M | 106.62 M | 105.83 M | 127.72 M | 135.84 M | 144.42 M | 148.97 M | 169.32 M | 199.90 M | |||||||||
| Low Estimate | 22.28 M | 26.69 M | 31.89 M | 45.93 M | 51.96 M | 50.53 M | 71.70 M | 74.03 M | 98.76 M | 87.17 M | 108.43 M | 111.91 M | 122.23 M | 127.65 M | 144.35 M | 163.91 M | |||||||||
| Consensus Estimate | 23.21 M | 27.68 M | 34.39 M | 49.75 M | 53.65 M | 54.60 M | 76.50 M | 81.71 M | 102.69 M | 96.50 M | 118.08 M | 123.87 M | 133.33 M | 138.31 M | 156.83 M | 181.90 M |
Analysts expect Phathom Pharmaceuticals, Inc. to report earnings per share of -0.07 for Q4 26, against a range of -0.08 to -0.06. The most recent reported quarter, Q3 26, came in at -0.16, a 60.0% miss against the -0.10 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.05 | -1.31 | -1.05 | -0.41 | -0.29 | -0.37 | -0.21 | -0.16 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.05 | -0.96 | -0.85 | -0.39 | -0.38 | -0.26 | -0.18 | -0.09 | -0.06 | -0.05 | 0.13 | 0.23 | 0.35 | 0.27 | 0.46 | 0.58 | |||||||||
| Low Estimate | -1.23 | -1.08 | -0.99 | -0.47 | -0.40 | -0.30 | -0.20 | -0.11 | -0.08 | -0.05 | 0.11 | 0.19 | 0.33 | 0.23 | 0.42 | 0.52 | |||||||||
| Consensus Estimate | -1.14 | -1.02 | -0.92 | -0.43 | -0.39 | -0.28 | -0.19 | -0.10 | -0.07 | -0.05 | 0.12 | 0.21 | 0.34 | 0.25 | 0.44 | 0.55 |
Pull Wall Street consensus for Phathom Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PHAT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PHAT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PHAT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();